Cornerstone Wealth Group
ARKG icon

Cornerstone Wealth Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cornerstone Wealth Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,828
Closed -$685K – 151
2019
Q1 		$685K Buy
+20,828
New +$615K 0.17% 107

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Carroll Financial Associates
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Cetera Advisor Networks
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Snowden Capital Advisors
Snowden Capital Advisors New York $4.23B AUM 29.95% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Stephens Inc
Stephens Inc Little Rock, Arkansas $9.06B AUM 17.42% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Cornerstone Wealth Group's ARKG Position: Q2 2019 in Review

Cornerstone Wealth Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2019, closing a stake of 20,828 shares — an estimated $685K sold.

Cornerstone Wealth Group first reported a position in ARKG in Q1 2019 and held it in 1 quarter. The position peaked at $685K in Q1 2019. 72 funds tracked by Wall St. Rank hold ARKG as of Q2 2019.

  • Cornerstone Wealth Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2019 after selling out during the quarter.
  • Cornerstone Wealth Group sold 20,828 ARK Genomic Revolution ETF shares in Q2 2019, an estimated $685K.
  • Cornerstone Wealth Group first reported a position in ARK Genomic Revolution ETF in Q1 2019 and held it in 1 quarter.
  • Cornerstone Wealth Group's ARK Genomic Revolution ETF position peaked at $685K in Q1 2019.
  • 72 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2019.

Based on Cornerstone Wealth Group's 13F filing for Q2 2019, filed 8 Aug 2019.